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ReviewP2X receptors are non-selective cation channels gated
by extracellular ATP. They play key roles in various
physiological processes such as nerve transmission,
pain sensation and the response to inflammation, mak-
ing them attractive drug targets for the treatment of
inflammatory pain. The recent report of the three-dimen-
sional (3D) crystal structure of zebrafish P2X4.1
represents a step change in our understanding of these
membrane ion channels, where previously only low-
resolution structural data and inferences from indirect
structure–function studies were available. The purpose
of this review is to place previous work within the
context of the new 3D structure, and to summarize
the key questions and challenges which await P2X
researchers as we move into the post-structure era.
Purinergic signalling and P2X receptors
The well-established field of purinergic signalling investi-
gates the effects of extracellular adenosine and adenine
nucleotides [1,2]. Purinergic receptors are classified into
three families: adenosine receptors (P1), ATP-gated ion
channels (P2X) and G-protein coupled receptors (P2Y).
ATP is released from synapses as a neurotransmitter, is
present at high local concentrations at sites of injury and
cell damage, and is also released by cells under mechanical
stress via as yet unknown mechanisms. The released ATP
acts directly on P2X and P2Y receptors, and is also con-
verted to ADP (which also acts on some P2Y receptors),
AMP and adenosine by multiple families of ecto-ATPases
at the cell surface [3]. The physiological effects of extra-
cellular purines are manifold; P2X receptors in particular
play key roles in synaptic transmission [4], taste sensation
[5] and control of smooth muscle [6,7]. The subtypes P2X4
and P2X7 are also critically involved in pain and inflam-
mation (Box 1), making them of particular interest to drug
companies as targets for analgesic and anti-inflammatory
therapies.
P2X receptors are widely expressed in many tissues,
and have been cloned from various eukaryotic organisms,
including mammals [8,9], zebrafish (Danio rerio) [10], flat-
worms (Schistosoma mansoni) [11], slime mould (Dictyos-
telium discoideum) [12], green algae (Ostreococcus tauri)
[13] and water bears (Hypsibius dujardini) [14]. However,
they do not appear to be present in the genomes of Dro-
sophila melanogaster, Caenorhabditis elegans, yeast or
prokaryotes, making their evolutionary origins something
of a mystery [15].Corresponding author: Young, M.T. (YoungMT@cardiff.ac.uk).
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termed P2X1 through P2X7. Functionally, P2X receptors
are non-selective ligand-gated cation channels. Upon bind-
ing ATP, they permit the passage of cations along their
electrochemical gradients; in cells this leads to the influx of
sodium and calcium. This in turn leads to depolarization of
the cell and downstream calcium signalling. The ATP
sensitivity and functional properties of P2X receptors vary
widely; for example, P2X1 is activated by nanomolar con-
centrations of ATP, and desensitizes rapidly, whereas
P2X7 requires high-micromolar concentrations of ATP,
and does not appear to desensitize [16]. Non-physiological
agonists such as (20-30)-benzoyl-benzoyl ATP (BzATP) are
more potent than ATP at P2X7 receptors; and more potent
at rat P2X7 than mouse P2X7 [17]. Furthermore, P2X
receptors display differential sensitivity to divalent
cations; for example, zinc potentiates ATP-evoked currents
at rat P2X2, but inhibits them at rat P2X7 [16].
In terms of their subunit arrangement and topology,
P2X receptors are distinct from other ligand-gated ion
channels. They are trimers [18,19], with two transmem-
brane (TM) domains per monomer and large (270 amino
acids), glycosylated extracellular domains. This topology is
similar to that of the acid-sensing ion channel family
(ASIC) [20,21], but P2X receptors and ASICs do not share
amino-acid similarity.
Until very recently, progress towards understanding
the structure of P2X receptors was slow, relying on
low-resolution studies and indirect structure–function
experiments. However, recent publication of the three-
dimensional (3D) structure of zebrafish P2X4.1 at a resol-
ution of 3.1 A˚ [22] represents the greatest advance in this
field since the cloning of the first P2X receptors in 1994.
The main aims of this review are to analyze the new
crystal structure within the context of key recent struc-
tural and structure–function experiments, assess its sig-
nificance to the P2X research community, and outline the
key questions which remain unanswered about this
important family of transmembrane ion channels.
The first P2X receptor structure
Kawate and colleagues reported the crystal structure of a
truncated mutant of the zebrafish P2X4.1 receptor
(DzfP2X4.1) [22]. 26- and 8-residue segments were removed
fromtheextremeN-andC-termini, respectively, togenerate
a construct which crystallized and diffracted to a resolution
of 3.5 A˚. Three further amino-acid substitutions (C51F,
N78K and N187R) were introduced into this construct to09.006 Available online 15 October 2009 83
Box 1. P2X receptors in pain and inflammation
P2X receptors are important drug targets primarily because of their
involvement in pain following nerve damage and inflammation. It
has been known for several years that ATP injection into the skin of
human volunteers causes pain, but the mechanisms governing this
sensation are unclear [56]. In a rat model of neuropathic pain (tactile
allodynia; animals become hypersensitive to pain after peripheral
nerve injury), Tsuda et al. found that knocking down levels of P2X4
via antisense oligonucleotides decreased hypersensitivity [57].
Additionally, neuropathic and inflammatory pain (hypersensitivity
of the paw following inflammation) was abolished in P2rx7 –/–mice,
although acute pain responses remained unchanged [58]. Further-
more, the selective P2X7 antagonist A-740003 was effective at
reducing neuropathic pain in rats [59].
P2X7 is also critically involved in inflammation; prolonged
activation of P2X7 in immune cells such as macrophages leads to
release of the pro-inflammatory cytokine interleukin-1b (IL-1b),
activation of the inflammasome and, at times, cell death [60,61].
ATP-stimulated release of IL-1b was abolished in macrophages
derived from P2rx7–/– mice [62], demonstrating the importance of
P2X7 in inflammatory signalling.
Recently, a new range of P2X7-selective antagonists have been
developed [63]. Of note, the P2X7 antagonist AZD9056 has provided
promising results in Phase-II clinical trials for the treatment of
rheumatoid arthritis [64]. These data raise hopes that new analgesic
and anti-inflammatory treatments which target P2X receptors will
soon be available.
Review Trends in Biochemical Sciences Vol.35 No.2reduce non-native disulfide bond formation and N-glycosyl-
ation, yielding crystals that diffracted to 3.1-A˚ resolution. It
is not uncommon for such extensive mutagenesis to be
required to render membrane proteins suitable for 3D crys-
tallization; membrane proteins are notoriously difficult to
work with, and this project was no different, reportedly
requiring seven years to come to fruition [23]. Determining
the effects of the mutagenesis on protein function is import-
ant. In this case, both constructs retained some level ofATP-
gated channel functionwhen expressed inmammalian cells;
however, it is apparent that receptor function was changed
[22]. Agonist sensitivity was increased as compared with
wild type, whereas maximum currents appeared to be
greatly reduced. The crystal structure will be different from
the structure of wild-type zfP2X4.1 because it was derived
fromamutant construct and themutationshada significant
effect on ion channel function. However, because the
DzfP2X4.1 construct retained some ion channel function,
it is a fairly safe assumption that structural differences
between the mutant construct and the wild-type receptor
will be relatively minor.
Regions of the DzfP2X4.1 protein sequence can be
related to domains within the crystal structure by imagin-
ing the monomer using the analogy of a leaping dolphin
[22] (Figure 1a, b). The body of the dolphin is a b-sandwich
domain which makes extensive subunit–subunit contacts
in the upper regions (Figure 1c); however there are rela-
tively few contacts in the regions proximal to the TM
domains. This conformation might allow the TM domains
the latitude to move upon agonist binding [22]. When the
atoms within the structure are shown in space-filling
representation, the dolphin-like monomer subunits are
entwined round one another, and cavities between sub-
units thought to be the ATP binding sites are clearly visible
(Figure 1d). There is no immediately obvious pathway for
ions through the TM domains, consistent with the expec-
tation that the crystallized protein is in a closed state.84What the structure tells us about P2X biology
The DzfP2X4.1 crystal structure shows the overall fold of
the closed state of the ion channel, confirming that P2X
receptors are trimers, and showing that the TM domains
are a-helical. In addition, the huge amount of detail within
the structure permits the analysis and interpretation of
previous work, in particular the large body of mutagenesis-
based structure-function studies. It is impressive to note
the high level of accuracy in the conclusions drawn from
these studies, given that they were made in the absence of
good homology models or structural data. Selected
examples of the accuracy of well-designed structure–func-
tion experiments are given below.
Disulfide bonds
All mammalian P2X receptors contain ten conserved
cysteine residues in their extracellular domains, which
are thought to form disulfide bond pairs. If we number
the cysteines from 1 to 10, from the N-terminus to the C-
terminus, the cysteines were previously predicted to be
paired in the order 1–6 (Cys119–Cys168; zfP2X4 number-
ing), 2–4 (Cys129–Cys152), 3–5 (Cys135–Cys162), 7–8 (Cys220–
Cys230) and 9–10 (Cys264–Cys273) [24,25]. This pairing
pattern was confirmed in the DzfP2X4 structure [22]
(Figure 2a, b). Disulfide pairs 1–6, 2–4 and 3–5 are all
located within the head region of the structure (Figure 2a),
whereas disulfide pair 7–8 is located in the dorsal fin
region, and disulfide pair 9–10 is located towards the
TM domains at the bottom of the body region
(Figure 2b). Interestingly, the two disulfide bonds com-
posed of cysteines 2–4 and 3–5 are very close together in
space, raising the possibility that these bonds could
exchange with each other during and after biosynthesis.
Agonist binding site
P2X receptors do not contain canonical ATP-binding
domains such as Walker motifs, and the nature of the
ATP binding site has been subject to much speculation
and experiment. Based upon mutagenesis data and bind-
ing studies, eight highly conserved residues have been
proposed to be involved in ATP binding. In zfP2X4.1 these
are Lys70, Lys72, Phe188, Thr189, Asn296, Phe297, Arg298 and
Lys316 [26–29]. The exact nature of the interaction of these
residues with ATP is poorly understood; the positively
charged residues Lys70, Lys72 and Lys316might be involved
in coordinating the negatively charged triphosphate
moiety [26], whereas Phe188, Thr189, Asn296, Phe297 and
Arg298might be involved in binding to the adenine ring and
ribose moiety [29]. Although the structure of DzfP2X4.1
was solved in the absence of ATP, these residues are
observed to line a cavity which forms between subunits
in the extracellular domain, strongly suggesting that this
is the location of the ATP binding site [22] (Figure 2c). Such
an inter-subunit ATP binding site is also consistent with
recent mutagenesis and crosslinking studies [27,30]. The
putative ATP binding pocket is surrounded by the ‘head’
and ‘left flipper’ domains of one subunit, and the ‘dorsal fin’
domains of another, so it is natural to suggest that amino-
acid differences in these regions might account for the
differential sensitivities of different P2X receptor subtypes
to divalent cations and agonists. By example, the rat P2X2
Figure 1. Representations of the DzfP2X4.1 structure. The first P2X receptor structure provides a wealth of new information about the overall fold of the molecule,
subunit–subunit interactions, and hints at the location of the ATP binding site. Regions of amino acid sequence (a) contributing to each domain within the DzfP2X4.1
crystal structure are shown in the same colors on a ribbon representation of a single subunit (b). The main chain electron density for residue Lys136 was unclear; this
residue is shown as a dashed line. The subunit structure resembles a ‘leaping dolphin’; TM domains (tail; green), head (pink), dorsal fin (orange), left flipper (yellow)
and right flipper (red) are indicated. (c) Sites of subunit–subunit interaction. Two subunits are shown, one (front) in ribbon representation and one (back) in space-
filling representation. Panels depict sites of significant interaction; head–body (i), left flipper–dorsal fin (ii), and body–body (iii). The direction of rotation of the
structure to obtain the views in panels (ii) and (iii) is indicated with curved arrows. (d) Space-filling representation of the trimer; individual subunits are colored red,
blue and green. The putative ATP-binding pocket is indicated, as are the dimensions of the extracellular and TM-domains. Figure partly redrawn from [22], with
permission.
Review Trends in Biochemical Sciences Vol.35 No.2receptor contains an inter-subunit zinc-binding site (rat
P2X2 activity is enhanced by zinc), contributed to by the
residues His120 and His231 (corresponding to Pro125 and
His219 in zfP2X4.1) [31]. In the DzfP2X4.1 structure these
residues are located in the head and dorsal fin regions, very
close to the putative ATP binding site (Figure 2c). Another
mutagenesis study suggested that the increased potency of
BzATP at rat P2X7 comparedwithmouse P2X7wasmostly
due to a single amino acid change (Lys127 in rat to Ala127 in
mouse) [17]. Interestingly, the corresponding residue in
zfP2X4.1 (Ser127) is positioned within the ‘head’ region,
very close to the putative ATP binding site (Figure 2c),
lending weight to the hypothesis that the benzoyl-benzoyl
group of BzATP might be involved in binding this residue.
A final illustration derives from a study by Adriouch et al,
demonstrating that, in mouse P2X7, the residue Arg125
could be ADP-ribosylated, leading to irreversible receptor
activation [32]. This residue corresponds to Pro125 in the
head region of zfP2X4.1 (Figure 2c), and is implicated in
zinc binding to rat P2X2, very near to the putative ATP
binding site. The structural interpretation of these data is
that the binding sites for ATP and ADP-ribose are in very
similar positions, exactly as proposed by Adriouch et al.
[32].
TM domains and the pore region
There is strong evidence from cysteine mutagenesis and
functional studies to suggest that the second TM (TM2) has
the major role in ion transduction, and that the channelpore narrows significantly toward the middle of the TM
domains [33–37]. The DzfP2X4.1 structure confirms these
results; the TM domains are highly tilted, with the three
TM2 subunits framing the pore, supported from the out-
side by the three TM1 subunits [22]. In the closed
DzfP2X4.1 structure the channel is blocked by predomi-
nantly hydrophobic residues for approximately 8 A˚ of its
length. Ala344 defines the narrowest section of the putative
pore gate; this residue corresponds to Thr336 in rat P2X2,
which has been proposed to be part of the narrowest part of
the pore in that channel subtype [35]. In summary, the
architecture of the pore in the DzfP2X4.1 structure agrees
very well with structure–function data, providing further
evidence that the structure accurately reflects that of the
wild-type, closed channel. The architecture of the P2X
receptor pore is very similar to that of the functional,
desensitized chicken ASIC1 structure [20]. This is surpris-
ing because the two receptors share no amino acid-
sequence similarity, and their 3D structures are very
different. Whether or not P2X receptors and ASICs are a
result of divergent evolution from one common ancestor, or
convergent evolution from two different proteins, remains
to be elucidated.
Signal transduction module
The region immediately N-terminal to TM2 (Arg304-Ile328;
rat P2X2 numbering) is highly conserved in P2X receptors,
and is critically involved in the transduction of ATP bind-
ing to channel gating [38–40]. The DzfP2X4.1 structure85
Figure 2. Structural interpretation of structure–function data. Previous structure–function studies, done in the absence of structural information, fit very well with the
DzfP2X4.1structure. (a) Close-up of the head domain (pink sequence in Figure 1a) demonstrating that the three disulfide bonds within this region form the
arrangement predicted [24,25]. Disulfides are shown in yellow and each cysteine is labelled with its corresponding residue number in the zfP2X4.1 sequence. (b)
Close-up of the body and dorsal fin regions of the DzfP2X4.1structure (shown in blue and orange, respectively), showing the positions of the remaining two disulfide
bonds (yellow) in the extracellular domain. (c) Close-up of the putative ATP binding cavity formed between two subunits. Key residues predicted to be involved
in ATP binding from structure–function experiments are indicated; Phe297 is not labelled but is shown in yellow behind Asn296 and Arg298. The positions of
residues which form part of an inter-subunit zinc binding site in rat P2X2 [31] are indicated by yellow asterisks (His219, bottom; Pro125, top). Ser127, a residue in the
head domain close to the ATP binding site which corresponds to Lys127 in rat P2X7 (thought to be involved in BzATP binding; [17]), is shown in purple. (d) Side-view
of one subunit showing the pre-TM2 region, which is critical for ion channel gating. Ser306, which corresponds to the glycosylated residue Asn298 in rat
P2X2, is shown in pink at the top of the structure. The region of pre-TM2 which caused most disruption to channel glycosylation and function in cysteine
mutagenesis experiments [40] is shown in red, whereas the region which tolerated cysteine mutants well is shown in yellow. Both regions are part of the same b-
strand; however, the red section appears to make more extensive contacts to other parts of the structure than the yellow section, giving a sensible interpretation to
the experimental data.
Review Trends in Biochemical Sciences Vol.35 No.2showed that this region is a b-strand that runs nearly the
full length of the extracellular domain [22] (Figure 2d). The
upper-half passes next to the putative ATP binding site,
where Lys316 (Lys308 in rat P2X2), a residue implicated in
ATP binding and gating [28,41], is located. The lower-half
of the pre-TM2 regionmakes fewer contacts with neighbor-
ing residues as it descends towards TM2. A recent struc-
ture–function study [40] showed that only amino acid
substitutions within the upper-half of the pre-TM2 region
in rat P2X2 (Arg304-Ile314; rat P2X2 numbering; Figure 2d)
caused a change in the conformation of the protein, which
was observed as alterations in N-linked glycosylation at
Asn298 (the most proximal N-glycosylation site). Although
this N-glycan site is not conserved in the DzfP2X4.1 struc-
ture, the corresponding region in the sequence alignment
(Ser306) is exposed at the top of the structure (Figure 2d).
By using the structure, a sensible interpretation of these
data can be provided; the upper-half of TM2 appears to be
involved in key protein–protein interactions, disruption of
which will disrupt the structure of the receptor. There are
fewer interactions in the lower-half of the pre-TM2 region
(Figure 1c), making it likely that point mutants within this
region would be less disruptive to the receptor structure.86This interpretation is supported by thework of Roberts and
Evans [38], who found that mutants within the lower-half
of the pre-TM2 region (Asp315-Ile328; rat P2X2 numbering)
had little effect on the function of rat P2X1, and Duckwitz
et al. [42], who found that alanine substitution in the lower-
half of the pre-TM2 region of a full-length human P2X5
construct had relatively little effect on channel function.
The sensitivity of the upper-half of the pre-TM2 region
to mutation, coupled with the fact that it contains a key
residue involved in ATP binding (Lys316; Lys308 in rat
P2X2), demonstrates the importance of this region of the
protein in ion-channel function. It is tempting to speculate
that the binding of ATP induces a conformational change in
the receptor structure which leads to a vertical movement
of the pre-TM2 region, causing TM2 to move relative to
TM1 and open the channel pore.
The future of P2X receptor structure–function studies
The DzfP2X4.1 structure has enabled analysis and
interpretation of previous structure–function work. In
addition, it will enable highly focused structure–function
studies using homology models of other P2X receptor sub-
types from different species. Data derived from these
Review Trends in Biochemical Sciences Vol.35 No.2studies will be more readily interpreted, and so it is
expected that there will be a significant increase in the
amount and effect of P2X receptor structure–function stu-
dies as a result of publication of the first crystal structure of
a P2X receptor.
Comparison of molecular models and low resolution
structures
The availability of a crystal structure permits assessment
of the accuracy of existing structural data for P2X recep-
tors, derived from computer modeling, atomic force micro-
scopy (AFM), and transmission electronmicroscopy. Before
publication of the DzfP2X4.1 crystal structure at 3.1-A˚
resolution, the highest resolution data obtained for P2X
receptors was approximately 20 A˚ [43,44]. Although much
less detail is present in low-resolution structure studies,
the conclusions are important for three main reasons: (i)
the studies are done on full-length, wild-type receptors; (ii)
they often provide estimates of overall size, shape and
particle volume which can be compared with high-resol-
ution data; and (iii) in some studies it has been possible to
record low-resolution data in the presence of ATP, enabling
the imaging of open channels.
Molecular models
Several molecular models have been proposed for part or
all of the P2X receptor sequence. Based on experimental
evidence from mutagenesis experiments, a 3D model of
conserved amino acids proposed to contribute directly to
ATP binding was generated [45]. With little other infor-
mation to draw upon, it is not surprising that the relative
positions of key residues are significantly different than in
the crystal structure. For example, the residues corre-
sponding to Phe188 and Phe297 are adjacent in the model
[45], but on opposite sides of the putative ATP binding
pocket in the structure [22] (Figure 2c).
Three further models of P2X receptors have been
described; all rely to some degree upon prediction of sec-
ondary structure. A model of P2X3, constructed using a
combination of secondary structure prediction and struc-
ture–function data, proposed the existence of four putative
ATP binding sites within a single subunit [46]. The possib-
ility of there being more than one ATP binding site per
monomer cannot be ruled out at present, but none of the
putative ATP binding sites resembles any part of the
DzfP2X4.1 crystal structure. A model of part of the extra-
cellular domain of rat P2X4 (residues 180–326), based upon
secondary structure similarity with aminoacyl-tRNA
synthetases, was constructed [47] and an intra-subunit
ATPbinding site proposed baseduponmutagenesis studies.
This shares no significant similarity with the DzfP2X4.1
crystal structure. The final model was of rat P2X2, based
upon a manually constructed secondary structure align-
ment with the ASIC using the chick DASIC1 structure
[21] as a template [48]. This model also shares little sim-
ilarity with the DzfP2X4.1 structure because, as we know
now, P2X and ASIC possess very different secondary struc-
tures and folds, although they do share striking similarities
in the shape of their transmembrane domains and pore
architecture [20]. In conclusion, the accuracy of the molecu-
lar models has suffered because of the absence of suitabletemplates for homology modeling. However, now that we
have a crystal structure towork from, futuremodels of other
P2X receptor subtypes should bemore accurate, providing a
wealth of testable hypotheses.
AFM
Direct structural studies were carried out on rat P2X2 and
rat P2X4 using AFM. This technique provides low-resol-
ution images of protein surfaces, and the sample mounting
technique can cause dehydration of biological specimens;
nevertheless, it can give impressive results. Nakazawa
et al. purified rat P2X2 over-expressed in insect cells
and imaged particles of approximately 10 nm in diameter
in the presence of ATP, and saw what appeared to be a
central depression indicative of a pore [49]. Barrera et al.
carried out elegant studies on rat P2X2 purified from over-
expression in human cells using antibodies against the C-
termini of the receptors, measuring an average angle of
1208 between antibodies on doubly labelled particles [18].
In this manner they provided evidence of the trimeric
nature of P2X receptors. They alsomeasured themolecular
volume of the imaged particles, finding it to be 409 nm3 on
average. This volume includes one fully glycosylated rat
P2X2 trimer (180 kDa), and a detergent micelle (approxi-
mate mass, 60 kDa), which is needed to protect the hydro-
phobic TM domains from the aqueous solvent during
protein purification. Dividing the volume by the total mass
gives a value of 1.7 nm3/kDa, which agrees reasonably well
with the value of 1.2 nm3/kDa for aDzfP2X4.1 trimer (mass
125 kDa, volume 155 nm3), estimated from the crystal
structure [22].
More recently, Shinozaki et al. used fast-scanning AFM
and single-particle averaging techniques to image rat
P2X4 trimers on a polylysine-coated mica substrate [50].
They showed that, in the absence of ATP, receptors
appeared as rounded triangles when viewed from the
top, having an approximate mean diameter of 12.6 nm,
which agrees well with previous data [49]. Strikingly, after
several minutes of treatment with 1 mM ATP, significant
structural changes were observed; the rounded triangle
separated into three discrete circular densities, which the
authors concluded was likely to indicate each subunit
moving away from a central pore as the channel opened.
Although the mean particle diameter was in close agree-
ment with previous studies, the mean particle height was
<4 nm, much shorter than the length of the DzfP2X4.1
structure (approximately 10 nm; [22] Figure 1d). This dis-
crepancy persisted when channels were imaged in lipid
bilayers, and might have resulted from the channels being
significantly tilted or bent [50].
Electron microscopy (EM)
EM and single-particle analysis (SPA) are powerful tech-
niques for the study of protein structure. Many thousands
of individual protein molecules are imaged, classified
according to their two-dimensional (2D) orientation on
the grid, and then combined in 3D space to produce a
structure. The simplest way to image proteins is by using
a negative stain such as uranyl acetate, which stains all
areas except where protein is present. The advantage of
negative stain is that it gives high-contrast images, but the87
Figure 3. The DzfP2X4.1 structure fits well within a low-resolution model of human P2X4. Top, side and bottom views of a manual fit of the DzfP2X4.1 trimer (green
ribbons) within the isosurface volume representation of human P2X4 (semi-transparent pink density) derived from electron microscopic analysis of purified single
protein particles [44]. The extracellular domain fit is quite good, but the TM domains in the single particle structure are surrounded by a detergent micelle, so they
appear rounded and do not fit well with the TM region of the crystal structure. The overall particle dimensions are consistent with those of the crystal structure.
Scale bar = 5 nm.
Review Trends in Biochemical Sciences Vol.35 No.2disadvantages are that: (i) resolution is limited to approxi-
mately 20 A˚ and (ii), for membrane proteins, the detergent
micelle which protects the TM domains is not penetrated
by the stain, precluding observation of the TM domain
architecture. (This is because the protein location and
orientation is inferred from the stain-excluded areas,
rather than by directly imaging the protein itself.)
To obtain informationathigher resolution, it is necessary
to employ cryo-EM techniques. Sample damage is mini-
mized by recording at very low temperatures, and samples
must be frozen very quickly to prevent formation of crystal-
line ice. This technique gives very low-contrast images but,
on large particles, preferably with a high degree of sym-
metry, can give resolutions of <10 A˚. A significant
additional advantage is that the proteinmolecule is directly
imaged, allowing visualization of the TM domains. How-
ever, due to technical limitations and sample damage pro-
blems, the practical size limit for cryo-EM is200 kDa [51].
Recently, Mio et al. generated a structure of rat P2X2,
purified from over-expression in insect cells, using EM and
SPA, first in negative stain, and then under cryo-conditions
[52,43]. Unfortunately, due to uneven staining, the authors
could not carry out 3D reconstruction in negative stain, but
they could provide a cartoon representation of the trimer,
with dimensions consistent with a molecule of volume
1200 nm3. The molecular mass one rat P2X2 trimer plus
a detergentmicelle is approximately 240 kDa, and dividing
the volume by the molecular mass gives a value of5 nm3/
kDa, which is much higher than that recorded for rat P2X2
by AFM or the DzfP2X4.1 crystal structure (1.7 and
1.2 nm3/kDa respectively; see above). The authors stated
that they observed a large, stain-permeable cavity within
the molecule, but did not assign its orientation [52]. A later
study by the same research team made use of cryo-con-
ditions, where the unstained protein molecules were
embedded in vitreous ice [43]. Rat P2X2 receptor trimers
are just below the practical mass cut-off for cryo-EM (200
kDa), so it is unsurprising to find that, even though>90000
automatically selected particles were used in the recon-88struction, a resolution of only 22 A˚ was achieved (as
measured by standard criteria) [43]. The final cryo-EM
structure of rat P2X2 shows two major discrepancies
versus the DzfP2X4.1 crystal structure. First, as for the
negative stain structure, the cryo-EM structure is much
bigger; it has dimensions of 202  160 A˚, compared with
100  75 A˚ for the crystal structure [22]. Second, the cryo-
EM structure has several large cavities running through it,
at positions inconsistent with those observed within the
crystal structure. The authors state that the volume
enclosed by the protein density within the cryo-EM struc-
ture is approximately 390 nm3, and encloses a mass of
324.5 kDa. Although the protein volume is consistent with
that obtained for rat P2X2 by AFM [18], themass of protein
within that volume is almost a factor of two greater than
the mass of one P2X2 trimer. It would be interesting to see
the volume for this protein structure displayed at a
threshold consistent with a mass of 180 kDa, but it is
likely that the density would be even more disjointed. A
simple interpretation of these data is that the single
particles imaged by EM were small, heterogeneous aggre-
gates of rat P2X2 trimers. Partial aggregation of rat P2X4
has been observed using EM [22]. Averaging and recon-
struction of small heterogeneous aggregates would also be
likely to lead to a final structure with significant internal
cavities.
EM studies of human P2X4 purified from over-expres-
sion in human cells [44] yielded a structure at 21-A˚ resol-
utionwhichwasmore consistent with the recentDzfP2X4.1
crystal structure. In this case, trimers were selectively
purified using non-denaturing gel electrophoresis, and
the particles imaged in negative stain. Domain-specific
labelling was used to correctly identify the propeller-
shaped side of the molecule as the extracellular domain
(Figure 3). The dodecyl maltoside (detergent) micelle prob-
ably explains the bulbous shape present at the other end of
the molecule (Figure 3). Nonetheless, the approximate
dimensions of the structure (12-nm long  8-nm wide)
agree well with those of the DzfP2X4.1 crystal structure.
Box 2. Key outstanding questions
1. Can the location of the ATP binding site be confirmed? How does
ATP bind?
2. How does ATP binding lead to channel opening and ion flux?
3. What is the structural basis for differential agonist and antagonist
sensitivity?
4. What is the structural basis for differential receptor desensitiza-
tion?
5. Which residues within the subunit–subunit contact regions are
important for trimer assembly and stability?
6. What is the structure of the TM domain in a lipid bilayer?
7. What effect do the N-and C-termini of P2X receptors have on
channel structure?
8. How do the structures of different P2X receptor subtypes differ
from zebrafish P2X4.1? For example, Dictyostelium P2XA is only
16% identical in amino-acid sequence; does it have the same
overall fold?
Review Trends in Biochemical Sciences Vol.35 No.2The molecular volume of the structure was 270 nm3, which
includes one human P2X4 trimer (165 kDa) and one 60-
kDa detergent micelle. Dividing the volume by the mol-
ecular mass gives a value of 1.2 nm3/kDa, which is entirely
consistent with the value obtained for the DzfP2X4.1 crys-
tal structure (also 1.2 nm3/kDa). In addition, the
DzfP2X4.1 crystal structure fits very well into the low-
resolution human P2X4 structure (Figure 3), and the fit
of the extracellular domain is particularly good.
The future of low-resolution studies
The advantage of low-resolution structural studies is that
the full-length, wild-type protein can often be imaged in a
near-native environment; however, the drawback is that
the achieved resolution is often much lower. In addition,
P2X receptors are below the practical size limit for high-
resolution cryo-EM and SPA. However, sub-nanometer
resolution could readily be achieved if the purified protein
could be induced to form 2D crystals upon reconstitution
into a lipid bilayer; this will presumably be a focus of future
efforts with human P2X4. A study of this nature would also
shed light on the dimensions and orientation of the TM
domains within the more physiological environment of a
lipid bilayer.
It is all in the expression
For those of us involved in studying P2X receptor struc-
ture, it is important to know how we might obtain the
highest yield of active protein for our experiments. The
answer seems clear: the baculovirus system can produce
protein of sufficient quality for 3D crystallography [22] as
well as functional P2X receptors [49,52,43,53,54]. Mam-
malian [18,44,53] cell systems also have been used to
express P2X receptors for structural and functional stu-
dies; it remains to be seen whether or not expression in
mammalian cells can lead to high-resolution membrane
protein structures.
Also of key importance is the purification of stable, tri-
meric forms of P2X receptors. Kawate et al. demonstrated
the power of fluorescence-based size-exclusion chromatog-
raphy in pre-screening of P2X receptor isoforms to select the
most stable trimers [22,55]. Pure trimers of P2X receptors
can also be isolated by electrophoresis in the presence of the
non-denaturing detergent perfluorooctanoic acid [44]. Therelative proportion of trimers varies with P2X receptor
subtype; for example, Dictyostelium P2XA trimers appear
tobemore stable than thoseof humanP2X4 [12]. The factors
governing subunit–subunit association and trimer stability
remain to be elucidated, but could prove important in
designing stable constructs of other P2X receptor subtypes
for structure study.
Concluding remarks
The recent report of the first crystal structure of a P2X
receptor [22] represents amajor advance in our understand-
ing of this unique and important family of ligand-gated ion
channels. This work has enabled the interpretation of a
large body of structure–function work, and assessment of
the accuracy of recent low-resolution structure studies. It
also highlights the great deal of work that is still to be done
(Box 2). This achievement serves as great encouragement to
others working within the field of membrane protein struc-
tural biology;membraneproteinsare not impossible towork
with and, with substantial effort, their structures can be
revealed. We hopefully will not have to wait long before
other P2X structures are available, from different subtypes
and indifferent activation states, enabling elucidationof the
mechanism of this important and fascinating family of ion
channels.
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